AAB-002

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameAAB-002
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunostimulantsAmyloid beta-protein precursor inhibitors
TargetsAmyloid beta-protein precursor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWyeth Holdings LLCElan Corporation Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Alzheimer Immunotherapy (Holding) LtdPfizer Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A